Seamus P Caragher1, Sean Sachdev2, Atique Ahmed1. 1. Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. 2. Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Abstract
PURPOSE OF THE REVIEW: Radiation became a pillar of oncologic treatment in the last century and provided a powerful and effective locoregional treatment of solid malignancies. After achieving some of the first cures in lymphomas and skin cancers, it assumed a key role in curative treatment of epithelioid malignancies. Despite success across a variety of histologic types, glioblastoma (GBM), the most common primary brain tumor afflicting adults, remains ultimately resistant to current radiation strategies. While GBMs demonstrate an initial response, recurrence is essentially universal and fatal, and typically reoccur in the areas that received the most intense radiation. RECENT FINDINGS: Glioma stem cells (GSCs), a subpopulation of tumor cells with expression profiles similar to neural stem cells and marked self-renewal capacities, have been shown to drive tumor recurrence and preclude curative radiotherapy. Recent research has shown that these cells have enhanced DNA repair capacity, elevated resistance to cytotoxic ion fluxes and escape multi-modality therapies. SUMMARY: We will analyze the current understanding of GSCs and radiation by highlighting key discoveries probing their ability to withstand radiotherapy. We then speculate on novel mechanisms by which GSC can be made sensitive to or specifically targeted by radiation therapy.
PURPOSE OF THE REVIEW: Radiation became a pillar of oncologic treatment in the last century and provided a powerful and effective locoregional treatment of solid malignancies. After achieving some of the first cures in lymphomas and skin cancers, it assumed a key role in curative treatment of epithelioid malignancies. Despite success across a variety of histologic types, glioblastoma (GBM), the most common primary brain tumor afflicting adults, remains ultimately resistant to current radiation strategies. While GBMs demonstrate an initial response, recurrence is essentially universal and fatal, and typically reoccur in the areas that received the most intense radiation. RECENT FINDINGS: Glioma stem cells (GSCs), a subpopulation of tumor cells with expression profiles similar to neural stem cells and marked self-renewal capacities, have been shown to drive tumor recurrence and preclude curative radiotherapy. Recent research has shown that these cells have enhanced DNA repair capacity, elevated resistance to cytotoxic ion fluxes and escape multi-modality therapies. SUMMARY: We will analyze the current understanding of GSCs and radiation by highlighting key discoveries probing their ability to withstand radiotherapy. We then speculate on novel mechanisms by which GSC can be made sensitive to or specifically targeted by radiation therapy.
Entities:
Keywords:
Cancer Stem Cells; Glioblastoma Multiforme; Radiation Oncology; Translational Oncology
Authors: J A Fritzell; L Narayanan; S M Baker; C E Bronner; S E Andrew; T A Prolla; A Bradley; F R Jirik; R M Liskay; P M Glazer Journal: Cancer Res Date: 1997-11-15 Impact factor: 12.701
Authors: June L Chan; Susan W Lee; Benedick A Fraass; Daniel P Normolle; Harry S Greenberg; Larry R Junck; Stephen S Gebarski; Howard M Sandler Journal: J Clin Oncol Date: 2002-03-15 Impact factor: 44.544
Authors: Sydney M Evans; Kevin D Judy; Isolde Dunphy; W Timothy Jenkins; Wei-Ting Hwang; Peter T Nelson; Robert A Lustig; Kevin Jenkins; Deirdre P Magarelli; Stephen M Hahn; Ruth A Collins; M Sean Grady; Cameron J Koch Journal: Clin Cancer Res Date: 2004-12-15 Impact factor: 12.531
Authors: M J Zelefsky; S A Leibel; P B Gaudin; G J Kutcher; N E Fleshner; E S Venkatramen; V E Reuter; W R Fair; C C Ling; Z Fuks Journal: Int J Radiat Oncol Biol Phys Date: 1998-06-01 Impact factor: 7.038
Authors: Matthias Osswald; Erik Jung; Felix Sahm; Gergely Solecki; Varun Venkataramani; Jonas Blaes; Sophie Weil; Heinz Horstmann; Benedikt Wiestler; Mustafa Syed; Lulu Huang; Miriam Ratliff; Kianush Karimian Jazi; Felix T Kurz; Torsten Schmenger; Dieter Lemke; Miriam Gömmel; Martin Pauli; Yunxiang Liao; Peter Häring; Stefan Pusch; Verena Herl; Christian Steinhäuser; Damir Krunic; Mostafa Jarahian; Hrvoje Miletic; Anna S Berghoff; Oliver Griesbeck; Georgios Kalamakis; Olga Garaschuk; Matthias Preusser; Samuel Weiss; Haikun Liu; Sabine Heiland; Michael Platten; Peter E Huber; Thomas Kuner; Andreas von Deimling; Wolfgang Wick; Frank Winkler Journal: Nature Date: 2015-11-04 Impact factor: 49.962
Authors: William M Bonner; Christophe E Redon; Jennifer S Dickey; Asako J Nakamura; Olga A Sedelnikova; Stéphanie Solier; Yves Pommier Journal: Nat Rev Cancer Date: 2008-11-13 Impact factor: 60.716
Authors: Boyoung Wee; Alexander Pietras; Tatsuya Ozawa; Elena Bazzoli; Ondrej Podlaha; Christophe Antczak; Bengt Westermark; Sven Nelander; Lene Uhrbom; Karin Forsberg-Nilsson; Hakim Djaballah; Franziska Michor; Eric C Holland Journal: Sci Rep Date: 2016-07-26 Impact factor: 4.379
Authors: Wei Wu; Jessica L Klockow; Suchismita Mohanty; Kimberly S Ku; Maryam Aghighi; Stavros Melemenidis; Zixin Chen; Kai Li; Goreti Ribeiro Morais; Ning Zhao; Jürgen Schlegel; Edward E Graves; Jianghong Rao; Paul M Loadman; Robert A Falconer; Sudip Mukherjee; Frederick T Chin; Heike E Daldrup-Link Journal: Nanotheranostics Date: 2019-09-17
Authors: Yun-Soo Seo; In Ok Ko; Hyejin Park; Ye Ji Jeong; Ji-Ae Park; Kwang Seok Kim; Myung-Jin Park; Hae-June Lee Journal: Front Oncol Date: 2019-11-15 Impact factor: 6.244